Evaluation of standardized uptake value to assess cerebral glucose metabolism

Clinical Nuclear Medicine

Volumn 25, Issue 1, 2000, Pages 11-16

  Yamaji, Shigeru ^a,b   Ishii, Kazunari ^a,c   Sasaki, Masahiro ^a   Mori, Tetsuya ^a   Kitagaki, Hajime ^a   Sakamoto, Setsu ^a   Mori, Etsuro ^a  

^a Hyogo Inst Aging Brain Cogn D   (Japan)

^b HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^c Hyogo Inst Aging Brain Cogn D   (Japan)

Author keywords

Alzheimer's Disease; Cerebral Glucose Metabolism; Fluorine 18 Fluorodeoxyglucose; Positron Emission Tomography; Standardized Uptake Value

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; FRONTAL CORTEX; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; MALE; METABOLIC RATE; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; SENSORIMOTOR CORTEX; TEMPORAL CORTEX;

AGED; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; DEOXYGLUCOSE; FEMALE; FLUORINE RADIOISOTOPES; GLUCOSE; HUMANS; MALE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033974118     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200001000-00003     Document Type: Article

References (27)

1. 14C]deoxy glucose method tor the measurement of local cerebral glucose utilization, theory, procedure, and normal values in the conscious and anaesthetized albino rat. J Neurochem 28:897, 1977.
2. Phelps ME, Huang SC, Hoffman EJ, et al: Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann Neurol 6:371, 1979.
3. 18F]fluorodeoxyglucose. J Comput Assist Tomogr 7:590, 1983.
4. Cutler NR, Haxby JV, Duara R, et al: Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease. Ann Neurol 18:298, 1985.
5. Duara R, Grady C, Haxby J, et al: Positron emission tomography in Alzheimer's disease. Neurology 36:879, 1986.
6. Jagust WJ: Functional imaging in dementia: An overview. J Clin Psychiatry 55(Suppl):5, 1994.
7. Salmon E, Sadzot B, Maquet P, et al: Differential diagnosis of Alzheimer's disease with PET. J Nucl Med 35:391, 1994.
8. Herholz K: FDG-PET and differential diagnosis of dementia. Alzheimer Dis Assoc Disord 9:6, 1995.
9. Gambhir SS, Schwaiger M, Huang S-C, et al: Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18-deoxyglucose. J Nucl Med 30:359, 1989.
10. Ohtake T, Kosaka N, Watanabe T, et al: Noninvasive method to obtain input function for measuring tissue glucose utilization of thoracic and abdominal organs. J Nucl Med 32:1432, 1991.
11. Takikawa S, Dhawan V, Spetsieris P, et al: Noninvasive quantitative fluorodeoxyglucose PET studies with an estimated input function derived from a population-based arterial blood curve. Radiology 188:131, 1993.
12. Strauss LG, Conti PS: The application of PET in clinical oncology. J Nucl Med 32:623, 1991.
13. Rigo P, Paulus P, Kaschten BJ, et al: Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose. Eur J Nucl Med 23:1641, 1996.
14. Oldendorf WH: Expression of tissue isotope distribution. J Nucl Med 15:725, 1974.
15. Suhonen-Polvi H, Ruotsalainen U, Kinnala A, et al: FDG-PET in early infancy: Simplified quantification methods to measure cerebral glucose utilization. J Nucl Med 36:1249, 1995.
16. McKhann G, Drachman D, Folstein M, et al: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939, 1984.
17. Mori E, Mitani Y, Yamadori A: Usefulness of Japanese version of the Mini-Mental State test in neurological patients. Jpn J Neuropsychiatry 1:82, 1985.
18. Ishii K, Sasaki M, Kitagaki H, et al: Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease. J Nucl Med 38:925, 1997.
19. Iida H, Miura S, Kanno I, et al: Design of evaluation of Headtome IV: A whole body positron emission tomograph. IEEE Trans Nucl Sci NS-37:1006, 1989.
20. Meltzer CC, Zubieta JK, Brandt J, et al: Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology 47:454, 1996.
21. Jagust WJ, Friedland RP, Budinger TF, Koss E, Ober B: Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 38:909, 1988.
22. Hirono N, Mori E, Ishii K, et al: Frontal lobe hypometabolism and depression in Alzheimer's disease. Neurology 50:380, 1998.
23. Minoshima S, Frey KA, Foster NL, Kuhl DE: Preserved pontine glucose metabolism in Alzheimer disease: A reference for functional brain image (PET) analysis. J Comput Assist Tomograph 19:541, 1995.
24. Herholz K, Perani D, Salmon G, et al: Comparability of FDG-PET studies in probable Alzheimer's disease. J Nucl Med 34:1460, 1993.
25. Keyes JW Jr: SUV: Standard uptake value or silly useless value? J Nucl Med 36:1836, 1995.
26. Hamberg LM, Hunter GJ, Alpert NM, et al: The dose uptake ratio as an index of glucose metabolism: Useful parameter or oversimplification? J Nucl Med 35:1308, 1994.
27. Piert M, Koeppe RA, Giordani B, Bernet S, Kuhl DE: Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med 37:201, 1996. (Shimadzu Corp., Kyoto, Japan)